As early adopters and long-time researchers deeply fascinated by the potential of peptides, we spent years navigating an industry that often felt like the Wild West
Introduction Rheumatoid arthritis (RA) is classified as a systemic poly-articular chronic autoimmune joint disease that primarily affects hands and feet
BPC-157 is a 15-residue, 1419.53 g/mol pentadecapeptide whose mechanistic literature centres on local angiogenic signalling, Hsieh and colleagues (J Mol Med, 2017) reported upregulation and internalisation of VEGFR2 in human endothelial cells, and Chang and colleagues (J Appl Physiol, 2011) reported increased FAK and paxillin phosphorylation with greater outgrowth and migration in cultured rat tendon fibroblasts
Its used for inflammatory conditions as well as tissue repair, tendon and ligament healing
KPV is a tripeptide, just three amino acids, from the C-terminal end of alpha-MSH
Some forum discussions focus on safety concerns, like if BPC-157 causes cancer